Last reviewed · How we verify

NCT04800289: RHUMPSO

Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist

Recruiting now Last updated 16 March 2021
What this trial tests

trial testing questionnaires in Psoriatic Arthritis in 600 participants. Currently enrolling.

Timeline
19 July 2020
Primary endpoint
31 July 2030
31 July 2030

Quick facts

Lead sponsorCentre Hospitalier le Mans
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment600
Start date19 July 2020
Primary completion31 July 2030
Estimated completion31 July 2030
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier le Mans

Who can join

18 and older, any sex, with Psoriatic Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Current increase in the number of multidisciplinary consultations, but little documentation on their impact on patient management. More specifically, in the context of psoriatic arthritis, we are seeking to investigate the interest for the patient, through his or her satisfaction and the evolution of the activity of his or her pathology, of a global, joint management in Rheumatology and Dermatology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionnaires

Trials testing the same drug.

Other recruiting trials for Psoriatic Arthritis

Currently open trials in the same condition.

Other Centre Hospitalier le Mans trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04800289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing